Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 148

1.

Tocilizumab-induced psoriasiform rash in rheumatoid arthritis.

Palmou-Fontana N, Sánchez Gaviño JA, McGonagle D, García-Martinez E, Iñiguez de Onzoño Martín L.

Dermatology. 2014;228(4):311-3. doi: 10.1159/000362266. Epub 2014 Jun 12.

PMID:
24942661
2.

Successful effect of tocilizumab in anti-TNF-α-induced palmoplantar pustulosis in rheumatoid arthritis.

Rueda-Gotor J, González-Gay MA, Blanco Alonso R, Gonzalez-Vela C, Lopez-Obregon C, González-López MA.

Joint Bone Spine. 2012 Oct;79(5):510-3. doi: 10.1016/j.jbspin.2012.06.010. Epub 2012 Aug 2.

PMID:
22857979
3.

[Psoriasis-like eruption induced by adalimumab in a patient with rheumatoid arthritis : a case report and review of literature].

Kuno H, Kotani T, Takeuchi T, Wakura D, Wakura R, Yu A, Makino S, Moriwaki S, Hanafusa T.

Nihon Rinsho Meneki Gakkai Kaishi. 2012;35(6):520-5. Review. Japanese.

4.

Palmoplantar subcorneal pustular dermatosis following adalimumab therapy for rheumatoid arthritis.

Sauder MB, Glassman SJ.

Int J Dermatol. 2013 May;52(5):624-8. doi: 10.1111/j.1365-4632.2012.05707.x. Epub 2013 Mar 14.

PMID:
23489057
5.

Toxidermia under treatment with tocilizumab for rheumatoid arthritis.

Fechtenbaum M, Banse C, Boyard-Lasselin P, Goëb V.

Joint Bone Spine. 2015 Jan;82(1):69-70. doi: 10.1016/j.jbspin.2014.06.006. Epub 2014 Jul 19. No abstract available.

PMID:
25048098
7.

Psoriasiform and pustular eruption induced by etanercept and infliximab.

Kuhara T, Watanabe D, Iwahori Y, Tamada Y, Yamamura M, Matsumoto Y.

Eur J Dermatol. 2009 Jul-Aug;19(4):388-9. doi: 10.1684/ejd.2009.0680. Epub 2009 May 25. No abstract available.

PMID:
19467963
8.

Plantar pustulosis during rituximab therapy for rheumatoid arthritis.

Brunasso AM, Massone C.

J Am Acad Dermatol. 2012 Oct;67(4):e148-50. doi: 10.1016/j.jaad.2011.12.010. No abstract available.

PMID:
22980273
9.

Psoriasis onset with tocilizumab.

Grasland A, Mahé E, Raynaud E, Mahé I.

Joint Bone Spine. 2013 Oct;80(5):541-2. doi: 10.1016/j.jbspin.2013.03.014. Epub 2013 Jun 2. No abstract available.

PMID:
23731639
10.

Infliximab can precipitate as well as worsen palmoplantar pustulosis: possible linkage to the expression of tumour necrosis factor-alpha in the normal palmar eccrine sweat duct?

Michaëlsson G, Kajermo U, Michaëlsson A, Hagforsen E.

Br J Dermatol. 2005 Dec;153(6):1243-4. No abstract available.

PMID:
16307676
11.

Safety of subcutaneous versus intravenous tocilizumab in combination with traditional disease-modifying antirheumatic drugs in patients with rheumatoid arthritis.

McLaughlin M, Östör A.

Expert Opin Drug Saf. 2015 Mar;14(3):429-37. doi: 10.1517/14740338.2015.998198. Epub 2015 Jan 2. Review.

PMID:
25553607
12.

Cytokine imbalance with increased production of interferon-alpha in psoriasiform eruptions associated with antitumour necrosis factor-alpha treatments.

Seneschal J, Milpied B, Vergier B, Lepreux S, Schaeverbeke T, Taïeb A.

Br J Dermatol. 2009 Nov;161(5):1081-8. doi: 10.1111/j.1365-2133.2009.09329.x. Epub 2009 Jun 5.

PMID:
19681863
13.

Tumor necrosis factor-associated palmoplantar pustular psoriasis treated with interleukin 6 blocker.

Younis S, Rimar D, Slobodin G, Rosner I.

J Rheumatol. 2012 Oct;39(10):2055-6. doi: 10.3899/jrheum.120304. No abstract available.

PMID:
23028035
14.

Anti-tumor necrosis factor alpha-induced psoriasiform eruptions: three further cases and current overview.

Pirard D, Arco D, Debrouckere V, Heenen M.

Dermatology. 2006;213(3):182-6.

PMID:
17033165
15.

Tocilizumab for treating rheumatoid arthritis: an evaluation of pharmacokinetics/pharmacodynamics and clinical efficacy.

Song SN, Yoshizaki K.

Expert Opin Drug Metab Toxicol. 2015 Feb;11(2):307-16. doi: 10.1517/17425255.2015.992779. Epub 2014 Dec 10. Review.

PMID:
25491492
16.

[Tocilizumab in rheumatoid arthritis].

Rueda Gotor J, Blanco Alonso R.

Reumatol Clin. 2011 Mar;6S3:S29-32. doi: 10.1016/j.reuma.2011.01.001. Epub 2011 Mar 23. Review. Spanish.

17.

Psoriasiform lesions induced by tumour necrosis factor antagonists: a skin-deep medical conundrum.

Carter JD, Gerard HC, Hudson AP.

Ann Rheum Dis. 2008 Aug;67(8):1181-3. doi: 10.1136/ard.2007.082842. Epub 2008 Feb 25.

PMID:
18299302
18.

Tumor necrosis factor-alpha inhibitor-induced psoriasis or psoriasiform exanthemata: first 120 cases from the literature including a series of six new patients.

Wollina U, Hansel G, Koch A, Schönlebe J, Köstler E, Haroske G.

Am J Clin Dermatol. 2008;9(1):1-14. Review. Erratum in: Am J Clin Dermatol. 2008;9(5):347.

PMID:
18092839
19.

Psoriasiform drug eruption due to abatacept.

Kato K, Satoh T, Nishizawa A, Yokozeki H.

Acta Derm Venereol. 2011 May;91(3):362-3. doi: 10.2340/00015555-1042. No abstract available.

Supplemental Content

Support Center